The Quest for a Life Free of Anti-rejection Drugs Following Living Donor Kidney Transplant:  FREEDOM-1 Clinical Trial

by Sara Douglas, RN and Kristi Schneider, MSN, RN

The Quest for a Life Free of Anti-rejection Drugs Following Living Donor Kidney Transplant:  FREEDOM-1 Clinical Trial Overview by Sara Douglas, RN and Kristi Schneider, MSN, RN of Talaris Therapeutics is a Renal Support Network Hope Week presentation. Hope Week is the Renal Support Network’s Annual Patient Education meeting. Hope Week is a five-day, national, virtual event. Each day is focused on a specific disease or treatment for kidney disease. Speakers include healthcare professionals and people who have learned to live and thrive in spite of having kidney disease.

Click here to learn more about Sara Douglas, RN and Kristi Schneider, MSN, RN

Click here to learn more about the Talaris FREEDOM-1 and FREEDOM-2 clinical trials

Web ID HW2216